US Patent Issued to KING FAISAL UNIVERSITY on Feb. 18 for "Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5thieno[2,3-dpyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5thieno[2,3-dpyrimidin-2-yl)benzamide as anti-inflammatory agents" (Indian, Malaysian, Saudi Arabia, Jordanian Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,516, issued on Feb. 18, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).

"Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5thieno[2,3-dpyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5thieno[2,3-dpyrimidin-2-yl)benzamide as anti-inflammatory agents" was invented by Katharigatta N. Venugopala (Al-Ahsa, Saudi Arabia), Pran Kishore Deb (Ranchi, India), Raghu Prasad Mailavaram (Dhule, India), Nizar A. Al-Shar'i (Irbid, Jordan), Swastika Ganguly (Ranchi, India), Bapi Gorain (Ranchi, India), Annie Lee Pei Wen (Kuala Lumpur, Malaysia) and Goh Hui Shan (Kuala Lumpur, Malaysia).

According to the abstract* rel...